Satouchi K et al. |
Application of selected ion monitoring to determination of platelet-activating factor. |
1983 |
J. Biochem. |
pmid:6423622
|
Hillmar I and Zöllner N |
Saturated and unsaturated 1-0-alkyl-2-0-acetoyl-sn-glycero-3-phosphocholines and 2-lyso derivatives from ratfish liver oil. Effect on adenosine 3':5'-cyclic monophosphate concentration in hepatocyte suspensions. |
1983 |
Res Exp Med (Berl) |
pmid:6310713
|
Mauco G et al. |
Platelet activating factor (PAF-acether) promotes an early degradation of phosphatidylinositol-4,5-biphosphate in rabbit platelets. |
1983 |
FEBS Lett. |
pmid:6311620
|
Camussi G et al. |
Release of platelet activating factor in rabbits with antibody-mediated injury of the lung: the role of leukocytes and of pulmonary endothelial cells. |
1983 |
J. Immunol. |
pmid:6311899
|
Hwang SB et al. |
Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes. |
1983 |
Biochemistry |
pmid:6313047
|
Shukla SD and Hanahan DJ |
An early transient decrease in phosphatidylinositol 4,5-bisphosphate upon stimulation of rabbit platelets with acetylglycerylether phosphorylcholine (platelet activating factor). |
1983 |
Arch. Biochem. Biophys. |
pmid:6320731
|
Wasserman SI |
Mediators of immediate hypersensitivity. |
1983 |
J. Allergy Clin. Immunol. |
pmid:6193157
|
MacIntyre DE and Pollock WK |
Platelet-activating factor stimulates phosphatidylinositol turnover in human platelets. |
1983 |
Biochem. J. |
pmid:6411067
|
Larsen GL and Henson PM |
Mediators of inflammation. |
1983 |
Annu. Rev. Immunol. |
pmid:6399978
|
Albert DH and Snyder F |
Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine by rat alveolar macrophages. Phospholipase A2 and acetyltransferase activities during phagocytosis and ionophore stimulation. |
1983 |
J. Biol. Chem. |
pmid:6401298
|
O'Flaherty JT et al. |
5-L-hydroxy-6,8,11,14-eicosatetraenoate potentiates the human neutrophil degranulating action of platelet-activating factor. |
1983 |
Biochem. Biophys. Res. Commun. |
pmid:6403011
|
Drapier JC et al. |
Lipid-mediator synthesis in peritoneal macrophages from mice injected with immunostimulants. |
1983 |
Biochim. Biophys. Acta |
pmid:6131693
|
Otsuka A et al. |
alpha-Adrenergic blocking action of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine in rats. |
1983 |
Clin Exp Hypertens A |
pmid:6133661
|
Jouvin-Marche E et al. |
Effect of the Ca2+ antagonist nifedipine on the release of platelet-activating factor (PAF-acether), slow-reacting substance and beta-glucuronidase from human neutrophils. |
1983 |
Eur. J. Pharmacol. |
pmid:6134631
|
Hopkins NK et al. |
Evidence for mediation of acetyl glyceryl ether phosphorylcholine stimulation of adenosine 3',5'-(cyclic)monophosphate levels in human polymorphonuclear leukocytes by leukotriene B4. |
1983 |
Biochim. Biophys. Acta |
pmid:6313071
|
Haddad ZH and Green A |
State--and dynamics--of the art: a current review. IgE-mediated immediate hypersensitivity reactions: cellular events and pharmacologic mediators. |
1983 |
J Asthma |
pmid:6190793
|
Mencia-Huerta JM et al. |
Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE. |
1983 |
J. Immunol. |
pmid:6315819
|
Czarnetzki B |
Increased monocyte chemotaxis towards leukotriene B4 and platelet activating factor in patients with inflammatory dermatoses. |
1983 |
Clin. Exp. Immunol. |
pmid:6317241
|
Stimler NP and O'Flaherty JT |
Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues. |
1983 |
Am. J. Pathol. |
pmid:6624879
|
Sano K et al. |
A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. Comparison of thrombin and collagen actions. |
1983 |
J. Biol. Chem. |
pmid:6218169
|
Vargaftig BB et al. |
Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent. |
1983 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:6221558
|
Voelkel NF et al. |
Platelet-activating factor causes pulmonary vasoconstriction and edema via platelet-independent leukotriene formation. |
1983 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:6221590
|
Kloprogge E et al. |
Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets. |
1983 |
Thromb. Res. |
pmid:6222507
|
Hartung HP |
Acetyl glyceryl ether phosphorylcholine (platelet-activating factor) mediates heightened metabolic activity in macrophages. Studies on PGE, TXB2 and O2- production, spreading, and the influence of calmodulin-inhibitor W-7. |
1983 |
FEBS Lett. |
pmid:6309563
|
Swendsen CL et al. |
1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine: a novel source of arachidonic acid in neutrophils stimulated by the calcium ionophore A23187. |
1983 |
Biochem. Biophys. Res. Commun. |
pmid:6407484
|
Bessin P et al. |
Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. |
1983 |
Eur. J. Pharmacol. |
pmid:6687572
|
Shukla SD et al. |
Acetylglyceryl ether phosphorylcholine. A potent activator of hepatic phosphoinositide metabolism and glycogenolysis. |
1983 |
J. Biol. Chem. |
pmid:6309795
|
Hallam TJ et al. |
The role of 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (AcGEPC) and palmitoyl-lysophosphatidate in the responses of human blood platelets to collagen and thrombin. |
1983 |
FEBS Lett. |
pmid:6617886
|
Roussi J et al. |
[Success of treatment with a low-molecular-weight heparin fraction in a case of pulmonary embolism complicated by heparin-induced thrombopenia]. |
1983 |
Nouv Rev Fr Hematol |
pmid:6622253
|
Valone FH and Goetzl EJ |
Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC). |
1983 |
Am. J. Pathol. |
pmid:6624880
|
Barradas MA et al. |
The effect of fenfluramine on collagen-induced platelet aggregation in vitro. |
1983 |
Br J Clin Pharmacol |
pmid:6626443
|
Korth R et al. |
1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholines: influence on aggregation and [3H]serotonin release of human thrombocytes. |
1983 |
Chem. Phys. Lipids |
pmid:6627525
|
Moschidis MC et al. |
Phosphono-platelet activating factor I. Synthesis of 1-O-hexadecyl-2-O-acetyl-glyceryl-3-(2-trimethyl ammonium-methyl) phosphonate and its platelet activating potency. |
1983 |
Chem. Phys. Lipids |
pmid:6627527
|
Heffner JE et al. |
Acetyl glyceryl ether phosphorylcholine-stimulated human platelets cause pulmonary hypertension and edema in isolated rabbit lungs. Role of thromboxane A2. |
1983 |
J. Clin. Invest. |
pmid:6822668
|
Vargaftig BB et al. |
Convulxin-induced activation of intact and of thrombin-degranulated rabbit platelets: specific crossed desensitisation with collagen. |
1983 |
Eur. J. Pharmacol. |
pmid:6628537
|
Keraly CL et al. |
Effect of structural analogues of PAF-acether on platelet desensitization. |
1983 |
Br. J. Haematol. |
pmid:6824590
|
Farr RS et al. |
Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor. |
1983 |
Fed. Proc. |
pmid:6628702
|
Tence M et al. |
The enantiomer and the positional isomer of platelet-activating factor. |
1983 |
Biochim. Biophys. Acta |
pmid:6824744
|
Denjean A et al. |
Acute effects of intratracheal administration of platelet-activating factor in baboons. |
1983 |
J Appl Physiol Respir Environ Exerc Physiol |
pmid:6629917
|
Camussi G et al. |
Biosynthesis and release of platelet-activating factor from human monocytes. |
1983 |
Int. Arch. Allergy Appl. Immunol. |
pmid:6826235
|
Randolph AE et al. |
Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats. |
1983 |
Clin Exp Hypertens A |
pmid:6684006
|
Morley J et al. |
Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin. |
1983 |
Br. J. Pharmacol. |
pmid:6685552
|
Hornby EJ and Perry CR |
1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen. |
1983 |
Thromb. Haemost. |
pmid:6636035
|
Patterson R and Harris KE |
The activity of aerosolized and intracutaneous synthetic platelet activating factor (AGEPC) in rhesus monkeys with IgE-mediated airway responses and normal monkeys. |
1983 |
J. Lab. Clin. Med. |
pmid:6644157
|
Nunn B |
Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation. |
1983 |
Thromb. Res. |
pmid:6648898
|
Myers A et al. |
Glucocorticoid protection against PAF-acether toxicity in mice. |
1983 |
Br. J. Pharmacol. |
pmid:6652344
|
Cervoni P et al. |
Aortic vascular and atrial responses to (+/-)-1-O-octadecyl-2-acetyl-glyceryl-3-phosphorylcholine. |
1983 |
Br. J. Pharmacol. |
pmid:6652348
|
Ogihara T et al. |
[Renomedullary hypotensive lipids and prostaglandins]. |
1983 |
Horumon To Rinsho |
pmid:6368051
|
Benveniste J et al. |
The actions of Paf-acether (platelet-activating factor) on guinea-pig isolated heart preparations. |
1983 |
Br. J. Pharmacol. |
pmid:6652376
|
Garcia Gil M and Sanchez Crespo M |
Dansylcadaverine and rimantadine inhibition of phagocytosis, PAF-acether release, and phosphatidylcholine synthesis in human polymorphonuclear leukocytes. |
1983 |
Immunopharmacology |
pmid:6654649
|
Tokumura A et al. |
Biphasic action of platelet-activating factor on isolated guinea-pig ileum. |
1983 |
Lipids |
pmid:6656539
|
Hamasaki Y et al. |
[Effects of platelet activating factor (PAF:AGEPC) on airway and pulmonary vascular constriction of guinea pigs--with special reference to the relation with TXA2]. |
1983 |
Kokyu To Junkan |
pmid:6658209
|
Björk J et al. |
Paf-acether (platelet-activating factor) increases microvascular permeability and affects endothelium-granulocyte interaction in microvascular beds. |
1983 |
Acta Physiol. Scand. |
pmid:6659994
|
Björk J and Smedegård G |
Acute microvascular effects of PAF-acether, as studied by intravital microscopy. |
1983 |
Eur. J. Pharmacol. |
pmid:6662199
|
Holt PG et al. |
Platelet serotonin release by human polymorphonuclear leucocytes stimulated by cotton dust bacteria. |
1983 |
Clin. Exp. Immunol. |
pmid:6831770
|
Yamashita M et al. |
The metabolism of platelet activating factor in platelets and plasma of various animals. |
1983 |
J Toxicol Sci |
pmid:6663653
|
McDonald TP and Kalmaz GD |
Effects of thrombopoietin on the number and diameter of marrow megakaryocytes of mice. |
1983 |
Exp. Hematol. |
pmid:6832243
|
Masugi F et al. |
[Kidney medulla and hypertension, with special reference to antihypertensive lipids]. |
1983 |
Nihon Jinzo Gakkai Shi |
pmid:6663856
|
Lewis JC et al. |
Platelet-activating factor effects on pulmonary ultrastructure in rabbits. |
1983 |
Exp. Mol. Pathol. |
pmid:6832335
|
Tanaka S et al. |
Studies on the hypotensive effects of platelet activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine) in rats, guinea pigs, rabbits, and dogs. |
1983 |
J. Pharmacobio-dyn. |
pmid:6668545
|
Levy JV |
Calmodulin antagonists inhibit aggregation of human, guniea pig and rabbit platelets induced with platelet activating factor. |
1983 |
FEBS Lett. |
pmid:6832368
|
Saeki S et al. |
Hypotensive activity of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine in rats with various types of hypertension. |
1983 |
Med J Osaka Univ |
pmid:6669136
|
Mueller HW et al. |
Biosynthesis of platelet activating factor in rabbit polymorphonuclear neutrophils. |
1983 |
J. Biol. Chem. |
pmid:6406476
|
Lee TC et al. |
Stimulation of calcium uptake by 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) in rabbit platelets: possible involvement of the lipoxygenase pathway. |
1983 |
Arch. Biochem. Biophys. |
pmid:6407399
|
Touqui L et al. |
Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite. |
1983 |
Biochem. Biophys. Res. Commun. |
pmid:6838557
|
Billah MM and Johnston JM |
Identification of phospholipid platelet-activating factor (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid and urine. |
1983 |
Biochem. Biophys. Res. Commun. |
pmid:6407483
|
Worthen GS et al. |
Platelet-activating factor causes neutrophil accumulation and edema in rabbit lungs. |
1983 |
Chest |
pmid:6839840
|
Heffner JE et al. |
Platelet-induced pulmonary hypertension and edema. A mechanism involving acetyl glyceryl ether phosphorylcholine and thromboxane A2. |
1983 |
Chest |
pmid:6839854
|
Levy JV |
Calmodulin antagonist W-7 inhibits aggregation of human platelets induced by platelet activating factor. |
1983 |
Proc. Soc. Exp. Biol. Med. |
pmid:6844347
|
O'Flaherty JT et al. |
Platelet-activating factor and analogues: comparative studies with human neutrophils and rabbit platelets. |
1983 |
Res. Commun. Chem. Pathol. Pharmacol. |
pmid:6844746
|
Valone FH and Goetzl EJ |
Specific binding by human polymorphonuclear leucocytes of the immunological mediator 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine. |
1983 |
Immunology |
pmid:6848449
|
Chilton FH et al. |
Metabolic fate of platelet-activating factor in neutrophils. |
1983 |
J. Biol. Chem. |
pmid:6853486
|
Chilton FH et al. |
Selective acylation of lyso platelet activating factor by arachidonate in human neutrophils. |
1983 |
J. Biol. Chem. |
pmid:6408071
|
Cargill DI et al. |
Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF). |
1983 |
Thromb. Haemost. |
pmid:6879508
|
Virella G et al. |
Release of PAF by human polymorphonuclear leucocytes stimulated by immune complexes bound to Sepharose particles and human erythrocytes. |
1983 |
Immunology |
pmid:6885111
|
Camussi G et al. |
Platelet-activating factor-mediated contraction of rabbit lung strips: pharmacologic modulation. |
1983 |
Immunopharmacology |
pmid:6885382
|
O'Flaherty JT and Wykle RL |
Biology and biochemistry of platelet-activating factor. |
1983 |
Clin Rev Allergy |
pmid:6370406
|
Tiffany ML |
Technical considerations for platelet aggregation and related problems. |
1983 |
Crit Rev Clin Lab Sci |
pmid:6370596
|
Vermylen J et al. |
Normal mechanisms of platelet function. |
1983 |
Clin Haematol |
pmid:6301715
|
Machin SJ et al. |
Defective platelet aggregation to the calcium ionophore A23187 in a patient with a lifelong bleeding disorder. |
1983 |
J. Clin. Pathol. |
pmid:6413552
|
Alam I et al. |
Metabolism of platelet-activating factor by blood platelets and plasma. |
1983 |
Lipids |
pmid:6413803
|
Pinckard RN |
Platelet-activating factor. |
1983 |
Hosp. Pract. (Off. Ed.) |
pmid:6414941
|
Camussi G et al. |
The release of platelet-activating factor from human endothelial cells in culture. |
1983 |
J. Immunol. |
pmid:6415166
|
Bonnet J et al. |
Dependency of the Paf-acether induced bronchospasm on the lipoxygenase pathway in the guinea-pig. |
1983 |
Prostaglandins |
pmid:6419289
|
Pazzi A et al. |
[Platelet activation in vivo. Electron microscopy study of a case of type II diabetes]. |
1983 Mar-Apr |
G Clin Med |
pmid:6884636
|
Mojarad M et al. |
Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary report. |
1983 May-Jun |
Bull Eur Physiopathol Respir |
pmid:6882949
|
Hopkins NK et al. |
Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer. |
1984 |
Biochim. Biophys. Acta |
pmid:6089913
|
Rao AK et al. |
Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects. |
1984 |
Am. J. Hematol. |
pmid:6431801
|
Siess W et al. |
Activation of phospholipase C is dissociated from arachidonate metabolism during platelet shape change induced by thrombin or platelet-activating factor. Epinephrine does not induce phospholipase C activation or platelet shape change. |
1984 |
J. Biol. Chem. |
pmid:6429141
|
Jackson EM et al. |
High performance liquid chromatography of platelet-activating factors. |
1984 |
J. Lipid Res. |
pmid:6481248
|
Dewar A et al. |
Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig. |
1984 |
J. Pathol. |
pmid:6481526
|
Goldstein BM et al. |
Effect of platelet activating factor (PAF) on blood flow distribution in the spontaneously hypertensive rat. |
1984 |
Life Sci. |
pmid:6482659
|
Baldo BA and Tovey ER |
Allergy, allergens and allergen standardization. |
1984 |
Med. J. Aust. |
pmid:6482786
|
Humphrey DM et al. |
Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine. |
1984 |
Lab. Invest. |
pmid:6694349
|
Masugi F et al. |
Effect of 1-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine inhibitor on the reduction of one-kidney, one clip hypertension after unclipping in the rat. |
1984 |
Life Sci. |
pmid:6694519
|
Bottecchia D et al. |
Influence of the pure synthetic PAF (platelet aggregating factor) on clot retraction and platelet aggregation. |
1984 |
Scand J Haematol |
pmid:6695148
|
McGivern DV and Basran GS |
Synergism between platelet-activating factor (PAF-acether) and prostaglandin E2 in man. |
1984 |
Eur. J. Pharmacol. |
pmid:6592097
|
Beaubien BB et al. |
Platelet-activating factor stimulation of peptidoleukotriene release: inhibition by vasoactive polypeptide. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6594998
|
Roubin R et al. |
The role of immunomodulators in the production of lipid mediators by macrophages (M phi). |
1984 |
Int J Tissue React |
pmid:6596298
|
Lefer AM et al. |
Pathophysiological mechanisms of sudden death induced by platelet activating factor. |
1984 |
Br. J. Pharmacol. |
pmid:6435705
|